Skip to content

AARD AARD Accrued Expenses

Accrued Expenses at other companies

Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$7.16M+80.5%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$80.05M+106%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$2.07M-5.5%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$39.14M+244%
Arvinas logo
ArvinasARVN
$4.5M-40.8%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$17.49M+47.7%

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's accrued expenses?
AARD (AARD) reported accrued expenses of $6.78M in Q1 2026.
How has AARD's accrued expenses changed year-over-year?
AARD's accrued expenses increased by 123.6% year-over-year, from $3.03M to $6.78M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.